Literature DB >> 24048069

Selection and adaptation during metastatic cancer progression.

Christoph A Klein1.   

Abstract

Cancer is often regarded as a process of asexual evolution driven by genomic and genetic instability. Mutation, selection and adaptation are by convention thought to occur primarily within, and to a lesser degree outside, the primary tumour. However, disseminated cancer cells that remain after 'curative' surgery exhibit extreme genomic heterogeneity before the manifestation of metastasis. This heterogeneity is later reduced by selected clonal expansion, suggesting that the disseminated cells had yet to acquire key traits of fully malignant cells. Abrogation of the cells' progression outside the primary tumour implies new challenges and opportunities for diagnosis and adjuvant therapies.

Entities:  

Mesh:

Year:  2013        PMID: 24048069     DOI: 10.1038/nature12628

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  101 in total

1.  Saltational evolution: hopeful monsters are here to stay.

Authors:  Günter Theissen
Journal:  Theory Biosci       Date:  2009-02-18       Impact factor: 1.919

Review 2.  Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.

Authors:  Sidney J Winawer; Ann G Zauber; Robert H Fletcher; Jonathon S Stillman; Michael J O'Brien; Bernard Levin; Robert A Smith; David A Lieberman; Randall W Burt; Theodore R Levin; John H Bond; Durado Brooks; Tim Byers; Neil Hyman; Lynne Kirk; Alan Thorson; Clifford Simmang; David Johnson; Douglas K Rex
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

Review 3.  Framework models of tumor dormancy from patient-derived observations.

Authors:  Christoph A Klein
Journal:  Curr Opin Genet Dev       Date:  2010-12-08       Impact factor: 5.578

4.  Aneuploidy theory explains tumor formation, the absence of immune surveillance, and the failure of chemotherapy.

Authors:  David Rasnick
Journal:  Cancer Genet Cytogenet       Date:  2002-07-01

5.  Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.

Authors:  M C Naski; Q Wang; J Xu; D M Ornitz
Journal:  Nat Genet       Date:  1996-06       Impact factor: 38.330

6.  Systemic spread is an early step in breast cancer.

Authors:  Yves Hüsemann; Jochen B Geigl; Falk Schubert; Piero Musiani; Manfred Meyer; Elke Burghart; Guido Forni; Roland Eils; Tanja Fehm; Gert Riethmüller; Christoph A Klein
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

7.  Characterization of epithelial cell adhesion molecule as a surface marker on undifferentiated human embryonic stem cells.

Authors:  Valerie Y Ng; Sheu Ngo Ang; Jia Xin Chan; Andre B H Choo
Journal:  Stem Cells       Date:  2010-01       Impact factor: 6.277

8.  Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.

Authors:  Ellen Heitzer; Martina Auer; Christin Gasch; Martin Pichler; Peter Ulz; Eva Maria Hoffmann; Sigurd Lax; Julie Waldispuehl-Geigl; Oliver Mauermann; Carolin Lackner; Gerald Höfler; Florian Eisner; Heinz Sill; Hellmut Samonigg; Klaus Pantel; Sabine Riethdorf; Thomas Bauernhofer; Jochen B Geigl; Michael R Speicher
Journal:  Cancer Res       Date:  2013-03-07       Impact factor: 12.701

9.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors:  H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

10.  The perivascular niche regulates breast tumour dormancy.

Authors:  Cyrus M Ghajar; Héctor Peinado; Hidetoshi Mori; Irina R Matei; Kimberley J Evason; Hélène Brazier; Dena Almeida; Antonius Koller; Katherine A Hajjar; Didier Y R Stainier; Emily I Chen; David Lyden; Mina J Bissell
Journal:  Nat Cell Biol       Date:  2013-06-02       Impact factor: 28.824

View more
  113 in total

Review 1.  [Mutational tumor profiles beyond organ and tissue specificity: implications for diagnostics and clinical study design].

Authors:  F Klauschen
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

2.  Tumor Heterogeneity--A 'Contemporary Concept' Founded on Historical Insights and Predictions.

Authors:  Danny R Welch
Journal:  Cancer Res       Date:  2016-01-03       Impact factor: 12.701

3.  Circulating Tumor Cells: Come Together, Right Now, Over Metastasis.

Authors:  Paulo Rodrigues; Sakari Vanharanta
Journal:  Cancer Discov       Date:  2019-01       Impact factor: 39.397

Review 4.  The evolution of tumour phylogenetics: principles and practice.

Authors:  Russell Schwartz; Alejandro A Schäffer
Journal:  Nat Rev Genet       Date:  2017-02-13       Impact factor: 53.242

Review 5.  Cancer Stem Cells in Squamous Cell Carcinoma.

Authors:  Zhe Jian; Alexander Strait; Antonio Jimeno; Xiao-Jing Wang
Journal:  J Invest Dermatol       Date:  2016-11-24       Impact factor: 8.551

Review 6.  Mechanism-based cancer therapy: resistance to therapy, therapy for resistance.

Authors:  P Ramos; M Bentires-Alj
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

7.  A Gene Regulatory Program in Human Breast Cancer.

Authors:  Renhua Li; John Campos; Joji Iida
Journal:  Genetics       Date:  2015-10-28       Impact factor: 4.562

Review 8.  Mechanisms of disseminated cancer cell dormancy: an awakening field.

Authors:  María Soledad Sosa; Paloma Bragado; Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2014-08-14       Impact factor: 60.716

Review 9.  Cell motility in cancer invasion and metastasis: insights from simple model organisms.

Authors:  Christina H Stuelten; Carole A Parent; Denise J Montell
Journal:  Nat Rev Cancer       Date:  2018-03-16       Impact factor: 60.716

Review 10.  The dynamic control of signal transduction networks in cancer cells.

Authors:  Walter Kolch; Melinda Halasz; Marina Granovskaya; Boris N Kholodenko
Journal:  Nat Rev Cancer       Date:  2015-08-20       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.